US 6984379
Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood
expired A61KA61K38/50A61K48/0008
Quick answer
US patent 6984379 (Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/50, A61K48/0008